SG11201603346VA - Lactobacillus crispatus and application thereof - Google Patents
Lactobacillus crispatus and application thereofInfo
- Publication number
- SG11201603346VA SG11201603346VA SG11201603346VA SG11201603346VA SG11201603346VA SG 11201603346V A SG11201603346V A SG 11201603346VA SG 11201603346V A SG11201603346V A SG 11201603346VA SG 11201603346V A SG11201603346V A SG 11201603346VA SG 11201603346V A SG11201603346V A SG 11201603346VA
- Authority
- SG
- Singapore
- Prior art keywords
- application
- lactobacillus crispatus
- crispatus
- lactobacillus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310551630.3A CN104630083B (en) | 2013-11-08 | 2013-11-08 | A kind of Lactobacillus crispatus and its application in feminine care products |
| CN201310551661 | 2013-11-08 | ||
| CN201310731833.0A CN104178437B (en) | 2013-11-08 | 2013-12-26 | A kind of Lactobacillus crispatus and the application in gynaecopathia thereof |
| PCT/CN2014/089882 WO2015067141A1 (en) | 2013-11-08 | 2014-10-30 | Lactobacillus crispatus and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201603346VA true SG11201603346VA (en) | 2016-05-30 |
Family
ID=53040891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201603346VA SG11201603346VA (en) | 2013-11-08 | 2014-10-30 | Lactobacillus crispatus and application thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9937214B2 (en) |
| EP (1) | EP3040413B1 (en) |
| JP (1) | JP6890419B2 (en) |
| KR (1) | KR101808972B1 (en) |
| ES (1) | ES2670536T3 (en) |
| MY (1) | MY172685A (en) |
| SG (1) | SG11201603346VA (en) |
| TW (1) | TWI652343B (en) |
| WO (1) | WO2015067141A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109874329A (en) * | 2016-08-12 | 2019-06-11 | 深圳华大生命科学研究院 | A kind of Faecalibacterium butyricum and its cultivation method and application |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018013583A2 (en) * | 2016-07-11 | 2018-01-18 | The Brigham And Women's Hospital, Inc. | Medicinal vaginal lactobacillus cocktail |
| JP7347760B2 (en) * | 2017-07-07 | 2023-09-20 | オセル、インコーポレイテッド | High potency and stable vaginal lactobacillus preparation |
| EP3648779A4 (en) * | 2017-07-07 | 2021-03-17 | Osel, Inc. | USE OF VAGINAL LACTOBACILLES TO IMPROVE IN VITRO FERTILIZATION SUCCESS RATE |
| EP3427745A1 (en) * | 2017-07-12 | 2019-01-16 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | New probiotic composition for prevention of bacterial vaginosis |
| HUE070746T2 (en) | 2017-10-06 | 2025-07-28 | Gedea Biotech Ab | Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections |
| EP3798299A4 (en) * | 2018-05-23 | 2022-03-30 | Ko Biolabs, Inc. | Lactobacillus crispatus kbl693 strain and use thereof |
| GB201816425D0 (en) * | 2018-10-09 | 2018-11-28 | Tervisetehnoloogiate Arenduskeskus As | Probiotics |
| CN109394796A (en) * | 2018-12-06 | 2019-03-01 | 青岛东海药业有限公司 | Lactobacillus crispatus preparation and its application |
| CN112458007A (en) * | 2020-11-10 | 2021-03-09 | 深圳华大生命科学研究院 | Lactobacillus crispatus for preventing and/or treating diseases related to genital tract flora disorder |
| FR3117340B1 (en) * | 2020-12-15 | 2024-01-05 | Basf Beauty Care Solutions France Sas | Cosmetic, nutraceutical or dermatological use of a strain of Lactobacillus crispatus and/or of a composition comprising it |
| US20240066078A1 (en) * | 2021-01-05 | 2024-02-29 | Lactobio A/S | Strains, compositions and methods of use |
| CN112899182B (en) * | 2021-01-08 | 2023-03-24 | 安徽省肿瘤医院 | Lactobacillus crispatus capable of preventing and/or treating cervical squamous cell carcinoma |
| CN113512509B (en) * | 2021-05-07 | 2022-02-22 | 南方医科大学珠江医院 | Lactobacillus crispatus and uses thereof |
| KR102618322B1 (en) * | 2021-10-08 | 2023-12-27 | 순천향대학교 산학협력단 | Novel Lactobacillus strain and composition for preventing, treating, or improving tuberculosis comprising the same |
| CN114214256B (en) * | 2022-01-12 | 2022-06-28 | 哈尔滨美华生物技术股份有限公司 | Lactobacillus gasseri for preventing and treating urogenital infection and application thereof |
| CN114657093B (en) * | 2022-03-07 | 2023-07-07 | 北京市农林科学院 | A pigeon-derived Lactobacillus crispatus BL4014 and its application |
| CN116814474B (en) * | 2022-05-19 | 2025-07-04 | 广东君薇生物科技有限公司 | A strain of Lactobacillus crispatus and its application |
| CN115404185A (en) * | 2022-08-31 | 2022-11-29 | 江苏新申奥生物科技有限公司 | Lactobacillus crispatus LCP051 for antagonizing candida albicans and application thereof |
| CN116024129B (en) * | 2022-11-29 | 2024-09-24 | 光明乳业股份有限公司 | Lactobacillus crispatus capable of co-aggregating with helicobacter pylori and application thereof |
| CN116694498A (en) * | 2023-01-31 | 2023-09-05 | 江南大学 | Vaginal probiotic composition for relieving various vaginitis |
| CN116286484B (en) * | 2023-02-08 | 2025-01-24 | 善恩康生物科技(苏州)有限公司 | Lactobacillus crispatus and its use |
| WO2024262189A1 (en) * | 2023-06-20 | 2024-12-26 | 東洋精糖株式会社 | Agent for suppressing proliferation of bacteria, and cosmetic, quasi-drug, and pharmaceutical composition containing said agent, and method for suppressing proliferation of bacteria |
| CN116769676B (en) * | 2023-08-09 | 2023-12-05 | 杭州微致生物科技有限公司 | Lactobacillus crispatus and application thereof |
| CN120330074A (en) * | 2024-01-17 | 2025-07-18 | 杭州远大生物制药有限公司 | Lactobacillus crispatus and its use |
| WO2025207473A1 (en) * | 2024-03-26 | 2025-10-02 | Medstar Health, Inc. | Methods and compositions for diagnosing and selectively treating or preventing urinary tract infection and urobiome dysbiosis |
| CN118256405B (en) * | 2024-05-31 | 2024-08-13 | 哈尔滨医科大学 | Lactobacillus crispatus FY121 and application of extracellular vesicles thereof in preventing and treating HPV infection and cervical cancer |
| CN119506125A (en) * | 2024-10-24 | 2025-02-25 | 北京科拓恒通生物技术股份有限公司 | A Lactobacillus crispatus capable of promoting female reproductive tract health and delaying reproductive tract immune aging |
| CN119326803B (en) * | 2024-12-19 | 2025-06-27 | 江西益百润生物科技有限公司 | Preparation method of metagen composition, product and application thereof |
| CN120648589A (en) * | 2025-05-23 | 2025-09-16 | 乾生(宁波)科技有限公司 | Probiotic for improving bacterial vaginitis, composition and application thereof |
| CN120775750A (en) * | 2025-09-09 | 2025-10-14 | 成都大学 | Lactobacillus crispatus and application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6093394A (en) * | 1997-04-11 | 2000-07-25 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
| US8329447B2 (en) * | 2008-12-12 | 2012-12-11 | Osel, Inc. | Strain of Lactobacillus crispatus |
| FR2992973B1 (en) * | 2012-07-09 | 2015-12-18 | S P M D | NEW STRAIN OF LACTOBACILLUS CRISPATUS |
| CN103074270A (en) * | 2012-11-15 | 2013-05-01 | 上海交大昂立股份有限公司 | Lactobacillus crispatus and application |
| CN104178437B (en) * | 2013-11-08 | 2016-08-24 | 苏州欧赛微科生物医药科技有限公司 | A kind of Lactobacillus crispatus and the application in gynaecopathia thereof |
| CN104630083B (en) * | 2013-11-08 | 2018-07-06 | 苏州欧赛微科生物医药科技有限公司 | A kind of Lactobacillus crispatus and its application in feminine care products |
-
2014
- 2014-10-30 WO PCT/CN2014/089882 patent/WO2015067141A1/en not_active Ceased
- 2014-10-30 MY MYPI2016000779A patent/MY172685A/en unknown
- 2014-10-30 US US15/034,503 patent/US9937214B2/en active Active
- 2014-10-30 KR KR1020167011287A patent/KR101808972B1/en active Active
- 2014-10-30 JP JP2016550923A patent/JP6890419B2/en active Active
- 2014-10-30 ES ES14860260.0T patent/ES2670536T3/en active Active
- 2014-10-30 SG SG11201603346VA patent/SG11201603346VA/en unknown
- 2014-10-30 EP EP14860260.0A patent/EP3040413B1/en active Active
- 2014-11-07 TW TW103138792A patent/TWI652343B/en active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109874329A (en) * | 2016-08-12 | 2019-06-11 | 深圳华大生命科学研究院 | A kind of Faecalibacterium butyricum and its cultivation method and application |
Also Published As
| Publication number | Publication date |
|---|---|
| KR101808972B1 (en) | 2017-12-13 |
| KR20160067893A (en) | 2016-06-14 |
| EP3040413A1 (en) | 2016-07-06 |
| MY172685A (en) | 2019-12-10 |
| TW201531560A (en) | 2015-08-16 |
| WO2015067141A1 (en) | 2015-05-14 |
| ES2670536T3 (en) | 2018-05-30 |
| TWI652343B (en) | 2019-03-01 |
| JP2017501741A (en) | 2017-01-19 |
| EP3040413B1 (en) | 2018-03-21 |
| US9937214B2 (en) | 2018-04-10 |
| EP3040413A4 (en) | 2016-07-06 |
| US20170020934A1 (en) | 2017-01-26 |
| JP6890419B2 (en) | 2021-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276106A (en) | Anti-garp protein and uses thereof | |
| SG11201603346VA (en) | Lactobacillus crispatus and application thereof | |
| IL261743B (en) | Anti-il-33 antibodies and uses thereof | |
| IL261547B (en) | Anti-hepcidin antibodies and uses thereof | |
| IL245040B (en) | Anti-pdgfr-beta antibodies and uses thereof | |
| IL243974A0 (en) | Anti-prlr antibodies and uses thereof | |
| ZA201508896B (en) | Anti-c10orf54 antibodies and uses thereof | |
| SG11201509116VA (en) | Anti-tweakr antibodies and uses thereof | |
| PT3058936T (en) | Peptide composition and uses thereof | |
| PL2777405T3 (en) | Novel Lactobacillus strains and the uses thereof | |
| GB201321693D0 (en) | Composition and uses thereof | |
| EP2968554A4 (en) | Met-binding agents and uses thereof | |
| GB201309178D0 (en) | Enzyme and uses thereof | |
| GB201320992D0 (en) | Complex and uses thereof | |
| ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
| GB201305297D0 (en) | Novel agents and uses thereof | |
| EP3006564A4 (en) | New peptide and application thereof | |
| GB201301640D0 (en) | Methods and peptides | |
| GB201301022D0 (en) | Composition and uses thereof | |
| GB201304166D0 (en) | CelebQuiff and Instant Quiff |